0001193125-23-088185.txt : 20230331 0001193125-23-088185.hdr.sgml : 20230331 20230331163702 ACCESSION NUMBER: 0001193125-23-088185 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20230331 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Magenta Therapeutics, Inc. CENTRAL INDEX KEY: 0001690585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38541 FILM NUMBER: 23788486 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 8-K 1 d436260d8k.htm 8-K 8-K
false 0001690585 --12-31 0001690585 2023-03-31 2023-03-31 0001690585 us-gaap:CommonStockMember 2023-03-31 2023-03-31 0001690585 us-gaap:PreferredStockMember 2023-03-31 2023-03-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 31, 2023

 

 

MAGENTA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38541   81-0724163
(State or other jurisdiction
of incorporation)		  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

100 Technology Square

Cambridge, Massachusetts 02139

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (857) 242-0170

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
symbol(s)

  

Name of each exchange
on which registered

Common Stock, $0.001 par value   MGTA   The Nasdaq Global Market
Preferred Stock Purchase Rights     The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

On March 31, 2023, the Board of Directors of Magenta Therapeutics, Inc. (the “Company”) adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March 31, 2023, between the Company and Computershare Trust Company, N.A., as Rights Agent (the “Rights Agreement”). The following description of the terms of the Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the Rights Agreement, which is included as Exhibit 4.1 and is incorporated herein by reference.

Pursuant to the terms of the Rights Agreement, the Board of Directors declared a dividend distribution of one Preferred Stock Purchase Right (a “Right”) for each outstanding share of common stock, par value $0.001 per share, of the Company (the “Common Stock”), to stockholders of record as of the close of business on April 11, 2023 (the “Record Date”). In addition, one Right will automatically attach to each share of Common Stock issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each Right entitles the registered holder thereof to purchase from the Company a unit consisting of one ten-thousandth of a share (a “Unit”) of Series A Junior Participating Cumulative Preferred Stock, par value $0.001 per share, of the Company (the “Preferred Stock”) at a cash exercise price of $3.75 per Unit (the “Exercise Price”), subject to adjustment, under certain conditions specified in the Rights Agreement and summarized below.

Initially, the Rights are not exercisable and are attached to and trade with all shares of Common Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the Common Stock and will become exercisable upon the earlier of (i) the close of business on the tenth calendar day following the first public announcement that a person or group of affiliated or associated persons (an “Acquiring Person”) has acquired beneficial ownership of 10% or more of the outstanding shares of Common Stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the “Stock Acquisition Date”), or (ii) the close of business on the tenth business day (or such later day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the “Distribution Date”). A person or group who beneficially owned 10% or more of the Company’s outstanding Common Stock prior to the first public announcement by the Company of the adoption of the Rights Agreement will not trigger the Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of Common Stock at a time when they still beneficially own 10% or more of such Common Stock, subject to certain exceptions as set forth in the Rights Agreement.

For purposes of the Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Rights Agreement are excepted from such imputed beneficial ownership.

In the event that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of Preferred Stock, that number of shares of Common Stock of the Company (or, in certain circumstances, including if there are insufficient shares of Common Stock to permit the exercise in full of the Rights, Units of Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the “Subscription Right”). In the event that, at any time following the Stock

Acquisition Date, (i) the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii) any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of Common Stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii) 50% or more of the Company’s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the “Merger Right”). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Rights Agreement) become null and void.

The Rights may be redeemed in whole, but not in part, at a price of $0.001 per Right (payable in cash, Common Stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i) the time at which any person becomes an Acquiring Person or (ii) the expiration date of the Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price.

The Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Rights Agreement, amend the Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates).

Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of Common Stock, other securities of the Company, other consideration or for common stock of an acquiring company.

The Rights are not exercisable until the Distribution Date and will expire at the close of business on March 30, 2024, unless previously redeemed or exchanged by the Company.

The Rights Agreement provides the holders of the Common Stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a “Qualifying Offer” (as defined in the Rights Agreement) from the terms of the Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i) a fully financed all-cash tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the Common Stock; and (ii) an offer that is otherwise in the best interests of the Company’s stockholders. The Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a “Qualifying Offer,” including if the consideration offered in a proposed transaction is stock of the acquiror.

Pursuant to the Rights Agreement, if the Company receives a Qualifying Offer and the Board has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Rights Agreement or called a special meeting of stockholders (the “Special Meeting”) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Rights Agreement, in each case by the end of the 90 business day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of 10% of the Common Stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Rights Agreement. If such a Special Meeting is not held by the 90th business day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Rights Agreement on the 10th business day thereafter.

Item 3.03. Material Modification to Rights of Security Holders.

The information in response to Item 1.01 is incorporated by reference in response to this Item 3.03.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

In connection with the adoption of the Rights Agreement described in Item 1.01 above, the Board of Directors of the Company approved a Certificate of Designations of Series A Junior Participating Cumulative Preferred Stock (the “Certificate of Designations”). The Certificate of Designations will be filed with the Secretary of State of Delaware on March 31, 2023. The Certificate of Designations is included as Exhibit 3.1 and is incorporated herein by reference. The description of the Series A Junior Participating Cumulative Preferred Stock in Item 1.01 is incorporated herein by reference.

Item 8.01. Other Events.

On March 31, 2023, the Company issued a press release announcing the adoption of the Rights Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.    Description
3.1    Certificate of Designations of Series A Junior Participating Cumulative Preferred Stock of Magenta Therapeutics, Inc. classifying and designating the Series A Junior Participating Cumulative Preferred Stock, filed as Exhibit 3.1 to the Company’s Registration Statement on Form 8-A on March 31, 2023 and incorporated herein by reference
4.1    Stockholder Rights Agreement, dated as of March 31, 2023, between Magenta Therapeutics, Inc. and Computershare Trust Company, N.A., as Rights Agent, filed as Exhibit 4.1 to the Company’s Registration Statement on Form 8-A on March 31, 2023 and incorporated herein by reference
99.1    Press Release issued by Magenta Therapeutics, Inc. dated March 31, 2023
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Magenta Therapeutics, Inc.
Date: March 31, 2023     By:  

/s/ Stephen Mahoney

      Stephen Mahoney
      President, Chief Financial and Operating Officer
 EX-99.1 2 d436260dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

Magenta Therapeutics Adopts Limited Duration Stockholder Rights Plan

Cambridge, MA – March 31, 2023 – Magenta Therapeutics, Inc. (Nasdaq: MGTA) (“Magenta” or the “Company”) today announced that its Board of Directors (the “Board”) has unanimously adopted a limited duration stockholder rights plan (the “Rights Plan”). The Rights Plan will give the Board sufficient time to conduct its previously announced comprehensive review of strategic alternatives focused on maximizing shareholder value. The Rights Plan has been adopted in order to protect the best interests of the Company and its shareholders, help ensure that all interested parties have the opportunity to participate fairly in the strategic review process, and provide the Board and shareholders time to make informed decisions. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company through open market accumulations or other tactics and reduce the likelihood that actions are taken by third parties that are not in the best interests of the Company and all of its shareholders.

The Rights Plan applies equally to all current and future shareholders and is not intended to deter offers or preclude the Board from considering offers that are fair and otherwise in the best interests of all the Company’s shareholders.

The Rights Plan provides several recognized shareholder protections, such as the following:

 

  •  

The Rights Plan will expire in one year, at the close of business on March 30, 2024.

 

  •  

The Rights Plan has an exception for offers made for all shares of the Company that treat all shareholders equally, including a qualifying offer clause that provides stockholders the ability to call a special meeting for purposes of exempting a “qualifying offer.”

 

  •  

The Rights Plan does not contain any dead-hand, slow-hand, no-hand or similar feature that would limit the ability of a future Board to redeem the rights.

Additional Information on Stockholder Rights Plan

The Rights Plan is similar to plans adopted by other publicly traded companies. Pursuant to the Rights Plan, Magenta declared a dividend distribution of one preferred stock purchase right for each outstanding share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), to stockholders of record as of the close of business on April 11, 2023 (the “Record Date”). In addition, one right will automatically attach to each share of Common Stock issued between the Record Date and the earlier of the distribution date and the expiration date of the rights. Each right entitles the registered holder thereof to purchase from the Company a unit consisting of one ten-thousandth of a share (a “Unit”) of Series A Junior Participating Cumulative Preferred Stock, par value $0.001 per share, of the Company (the “Preferred Stock”) at a cash exercise price of $3.75 per Unit, subject to adjustment, under certain conditions specified in the Rights Plan and summarized below.

The rights will become exercisable if an entity, person or group acquires beneficial ownership of 10% or more of the Company’s outstanding Common Stock. In the event that the rights become exercisable due to the triggering ownership threshold being crossed, each right will entitle its holder (other than the person, entity or group triggering the Rights Plan, whose rights will become void and will not be exercisable) to receive shares of Common Stock having a market value equal to two times the exercise price of the right. In the event of a merger or similar change of control of the Company, each right will entitle its holder (other than the person, entity or group triggering the Rights Plan, whose rights will become void and will not be exercisable) to receive shares of common stock of the acquiring company having a market value equal to two times the exercise price of the right.

Under the Rights Plan, any person, entity or group that currently owns more than the triggering percentage may continue to own its shares of Common Stock but may not acquire any additional shares of Common Stock, or form a group with another owner of Common Stock, without triggering the Rights Plan.

A copy of the Rights Plan and a summary of its terms will be filed on a Form 8-K with the Securities and Exchange Commission.

Advisors

Goodwin Procter LLP is serving as legal counsel for Magenta and Houlihan Lokey, Inc. is serving as financial advisor.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. These statements include, without limitation, implied and express statements relating to the anticipated benefits and expected consequences of the rights plan that Magenta has adopted. Words such as “anticipate,” “believe,” “continue,” “could,” “designed,” “endeavor,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “preliminary,” “will,” “would” and similar expressions are intended to identify forward-looking statements. The express or implied forward-looking statements included in this press release are based on current expectations, are only predictions and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those indicated, including, without limitation, the effectiveness of the rights plan in providing the Board of Directors with time to make informed decisions that are in the best long-term interests of Magenta and its stockholders. These and other risks are described in additional detail in Magenta’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and its other filings made with the Securities and Exchange Commission from time to time. Any forward-looking statements contained in this press release represent Magenta’s views only as of today and should not be relied upon as representing its views as of any subsequent date. Magenta explicitly disclaims any obligation to update any forward-looking statements, except to the extent required by law.

Contact:

investor@magentatx.com

EX-101.SCH 3 mgta-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 4 mgta-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 mgta-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock [Member] Common Stock [Member] Preferred Stock [Member] Preferred Stock [Member] EX-101.PRE 6 mgta-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 g436260g0331023958527.jpg GRAPHIC begin 644 g436260g0331023958527.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
Mar. 31, 2023
Document And Entity Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001690585
Current Fiscal Year End Date --12-31
Document Type 8-K
Document Period End Date Mar. 31, 2023
Entity Registrant Name MAGENTA THERAPEUTICS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-38541
Entity Tax Identification Number 81-0724163
Entity Address, Address Line One 100 Technology Square
Entity Address, City or Town Cambridge
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02139
City Area Code (857)
Local Phone Number 242-0170
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Common Stock [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Common Stock, $0.001 par value
Trading Symbol MGTA
Security Exchange Name NASDAQ
Preferred Stock [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Preferred Stock Purchase Rights
Security Exchange Name NASDAQ
XML 9 d436260d8k_htm.xml IDEA: XBRL DOCUMENT 0001690585 2023-03-31 2023-03-31 0001690585 us-gaap:CommonStockMember 2023-03-31 2023-03-31 0001690585 us-gaap:PreferredStockMember 2023-03-31 2023-03-31 false 0001690585 --12-31 8-K 2023-03-31 MAGENTA THERAPEUTICS, INC. DE 001-38541 81-0724163 100 Technology Square Cambridge MA 02139 (857) 242-0170 false false false false Common Stock, $0.001 par value MGTA NASDAQ Preferred Stock Purchase Rights NASDAQ true false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 3 24 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [dq-0546-SecurityExchangeName-TradingSymbol, NoTradingSymbolFlag-Dependency] In submission type 8-K, SecurityExchangeName may have a value if one of TradingSymbol, NoTradingSymbolFlag has a value in context duration_2023-03-31_to_2023-03-31_us-gaap-StatementClassOfStockAxis_us-gaap-PreferredStockMember. d436260d8k.htm 71 d436260d8k.htm d436260dex991.htm mgta-20230331.xsd mgta-20230331_def.xml mgta-20230331_lab.xml mgta-20230331_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d436260d8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "mgta-20230331_def.xml" ] }, "inline": { "local": [ "d436260d8k.htm" ] }, "labelLink": { "local": [ "mgta-20230331_lab.xml" ] }, "presentationLink": { "local": [ "mgta-20230331_pre.xml" ] }, "schema": { "local": [ "mgta-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 2, "nsprefix": "mgta", "nsuri": "http://www.magentatx.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d436260d8k.htm", "contextRef": "duration_2023-03-31_to_2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d436260d8k.htm", "contextRef": "duration_2023-03-31_to_2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "mgta_DocumentAndEntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "localname": "DocumentAndEntityInformationLineItems", "nsuri": "http://www.magentatx.com/20230331", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "mgta_DocumentAndEntityInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "localname": "DocumentAndEntityInformationTable", "nsuri": "http://www.magentatx.com/20230331", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.magentatx.com//20230331/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 17 0001193125-23-088185-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-088185-xbrl.zip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end